Desonide Lotion label

Desonide Lotion

Desonide Lotion Recall

Get an alert when a recall is issued.

Side Effects & Adverse Reactions

There is currently no warning information available for this product. We apologize for any inconvenience.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

Desonide Lotion is low to medium potency corticosteroids indicated for the relief of the Inflammatory and pruritic manifestations of corticosteroid responsive dermatoses.

History

There is currently no drug history available for this drug.

Other Information

Desonide Lotion 0.05% contains desonide (Pregna-1,4-diene-3,20-dione,11,21-dihydroxy-16,17 -[(1-melhylethylidene)bis(oxy)]-,(11β, 16α)- a synthetic nonfluorinated corticosteroid for topical dermatologic use. The corticosteroids constitute a class of primarily synthetic steroids used topically as anti-inflammatory and anti-pruritic agents.

Chemically, desonide is C
24H
320
6. It has the following structural formula:

desonide-lotion-01

Desonide has the molecular weight of 416.51. It is a white to off white odorless powder which is soluble in methanol and practically insoluble in water. Each gram of Desonide Lotion contains 0.5 mg of desonide in a base of cetyl alcohol, edetate sodium, glyceryl stearate SE, light mineral oil, methylparaben, propylene glycol, propylparaben, purified water, sodium lauryl sulfate, sorbitan monostearate, and stearyl alcohol. May contain citric acid and/or sodium hydroxide for pH adjustment.

Desonide Lotion Manufacturers

  • Physicians Total Care, Inc.
    Desonide Lotion | Physicians Total Care, Inc.
    No Recall

    Desonide Lotion | Physicians Total Care, Inc.

    Desonide Lotion | Physicians Total Care, Inc.
    Desonide Lotion should be applied to the affected areas as a thin film two or three times daily depending on the severity of the condition. SHAKE LOTION WELL BEFORE USING.
    As with other corticosteroids, therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, reassessment of diagnosis may be necessary.
    Desonide Lotion should not be used with occlusive dressings.
  • Desonide Lotion | Actavis Mid Atlantic Llc, Lincolnton, Nc 28092
    No Recall

    Desonide Lotion | Actavis Mid Atlantic Llc, Lincolnton, Nc 28092

    Desonide Lotion | Actavis Mid Atlantic Llc, Lincolnton, Nc 28092

    Desonide Lotion should be applied to the affected areas as a thin film two or three times daily depending on the severity of the condition. SHAKE LOTION WELL BEFORE USING.
    As with other corticosteroids, therapy should be discontinued when control is achieved. If no improvement is seen within 2 weeks, reassessment of diagnosis may be necessary.
    Desonide Lotion should not be used with occlusive dressings.

  • E. Fougera & Co. A Division Of Fougera Pharmaceuticals Inc.
    Desonide Lotion | Allergan, Inc.
    No Recall

    Desonide Lotion | Allergan, Inc.

    Desonide Lotion | Allergan, Inc.

    Invert the unit dose vial a few times to obtain a uniform, white, opaque emulsion before using. Instill one drop of RESTASIS® ophthalmic emulsion twice a day in each eye approximately 12 hours apart. RESTASIS® can be used concomitantly with artificial tears, allowing a 15 minute interval between products. Discard vial immediately after use.